Treatment for infections with carbapenem-resistant Enterobacteriaceae: What options do we still have?

Abstract

The global spread of carbapenem-resistant Enterobacteriaceae (CRE) is increasingly becoming a major challenge in clinical and public health settings. To date, the treatment for serious CRE infections remains difficult. The intelligent use of antimicrobials and effective infection control strategies is crucial to prevent further CRE spread. Early consultation with experts in the treatment of infections with multidrug-resistant organisms is valuable in patient management. This brief review will focus on the current, yet limited, treatment options for CRE infections. © 2014 Yamamoto and Pop-Vicas; licensee BioMed Central Ltd.